corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 11906

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Pfizer Chairman: Asia Offers Great Opportunities For Multinationals
Nikkei English News 2007 Oct 29
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1577970&contentType=sentryarticle&channelID=33


Full text:

TOKYO (Nikkei)—Multinational companies cannot ignore Asia due to the size of the region’s population and the speed of its economic growth, Pfizer Inc. Chairman Jeffrey Kindler said at an international business conference in Tokyo on Monday.

“No global company can afford not to invest in Asia. The opportunities are too great,” he said at the ninth Nikkei Global Management Forum. “By 2050, drug sales in Asia will be larger than in any other region of the world,” he added.

Speaking about the development of new drugs, Kindler said Pfizer will try to “add the ability to move as fast as the newest entrepreneurial start-up.”

He also stressed the importance of promoting the protection of patents and other types of intellectual property, saying the development of pharmaceutical and other research-oriented companies can become the engine of economic growth.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.